SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIGOLIN, Gian Matteo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.529
AS - Asia 9.724
EU - Europa 7.317
SA - Sud America 1.617
AF - Africa 131
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 37.348
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.105
SG - Singapore 3.893
CN - Cina 2.939
IT - Italia 2.077
BR - Brasile 1.348
DE - Germania 1.342
UA - Ucraina 1.033
HK - Hong Kong 930
TR - Turchia 786
GB - Regno Unito 651
VN - Vietnam 592
FI - Finlandia 449
SE - Svezia 356
RU - Federazione Russa 351
FR - Francia 350
PL - Polonia 228
MX - Messico 199
CA - Canada 187
ID - Indonesia 153
NL - Olanda 125
IN - India 120
AR - Argentina 111
ZA - Sudafrica 78
BE - Belgio 77
BD - Bangladesh 68
CZ - Repubblica Ceca 63
JP - Giappone 62
ES - Italia 54
EC - Ecuador 53
AT - Austria 38
LT - Lituania 37
IQ - Iraq 36
CL - Cile 21
CO - Colombia 20
VE - Venezuela 20
PK - Pakistan 19
PY - Paraguay 17
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 13
AU - Australia 13
CH - Svizzera 13
IE - Irlanda 13
MA - Marocco 13
IR - Iran 12
KE - Kenya 11
UY - Uruguay 11
IL - Israele 10
PE - Perù 10
RO - Romania 10
DO - Repubblica Dominicana 9
YE - Yemen 9
AZ - Azerbaigian 8
EU - Europa 8
MY - Malesia 8
KR - Corea 7
EG - Egitto 6
PT - Portogallo 6
SA - Arabia Saudita 6
SV - El Salvador 6
TN - Tunisia 6
AL - Albania 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
NZ - Nuova Zelanda 5
BO - Bolivia 4
DZ - Algeria 4
KG - Kirghizistan 4
LV - Lettonia 4
PA - Panama 4
SN - Senegal 4
BG - Bulgaria 3
BY - Bielorussia 3
DK - Danimarca 3
GE - Georgia 3
HR - Croazia 3
KW - Kuwait 3
MD - Moldavia 3
OM - Oman 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
GD - Grenada 2
GR - Grecia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NP - Nepal 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
ET - Etiopia 1
Totale 37.322
Salva come PNG Salva come JPEG
Città #
Singapore 2.194
Ashburn 1.816
Woodbridge 1.778
Fairfield 1.672
Houston 1.209
Jacksonville 1.120
Beijing 1.110
Chandler 1.097
Hong Kong 928
Santa Clara 919
Ann Arbor 790
Seattle 674
Wilmington 645
Cambridge 561
Izmir 438
Nanjing 369
Dallas 342
Los Angeles 339
New York 327
Munich 310
Princeton 288
Ferrara 268
Milan 244
Warsaw 209
Ho Chi Minh City 165
Boardman 160
San Diego 158
Shanghai 157
São Paulo 151
Mexico City 135
Jakarta 121
Turku 120
Nanchang 116
Shenyang 113
Hanoi 109
Dong Ket 108
Rome 105
Bremen 100
Addison 99
Helsinki 89
Buffalo 88
London 78
Brussels 77
Chicago 77
Tianjin 77
Hefei 75
Hebei 70
Jiaxing 68
Dearborn 62
Changsha 61
Montreal 61
Moscow 59
Brooklyn 57
Toronto 56
Rio de Janeiro 55
Tokyo 55
Denver 52
Bologna 50
Stockholm 48
Orem 46
Jinan 45
Falls Church 44
Johannesburg 44
Poplar 44
Brno 41
Norwalk 41
Phoenix 41
San Francisco 37
Falkenstein 36
Naples 36
Redwood City 36
Boston 35
Zhengzhou 35
Frankfurt am Main 34
Mountain View 34
San Mateo 34
Chennai 33
Atlanta 32
Manchester 32
Florence 31
Salt Lake City 31
Bari 28
Verona 27
Brasília 26
Augusta 25
Biên Hòa 24
Kunming 24
San Jose 24
Guangzhou 23
Lappeenranta 23
Da Nang 22
Haiphong 22
Mumbai 22
Ningbo 22
Nuremberg 22
Ottawa 21
Parma 21
Washington 21
Olomouc 20
Querétaro 20
Totale 24.138
Salva come PNG Salva come JPEG
Nome #
Ripristino dell’apoptosi mediata da p53: ruolo degli inibitori di MDM2. 1.067
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 260
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 238
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival 237
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 237
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 232
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 232
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 232
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 231
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 227
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 225
A case of disseminated Langerhans' cell histiocytosis treated with thalidomide 220
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 217
A case of advanced Hodgkin lymphoma with breast involvement treated with a combination of gemcitabine and pegylated liposomal doxorubicin. 216
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 216
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 216
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 215
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 214
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 214
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 213
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 212
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 212
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 212
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 211
Fisiologia piastrinica. 208
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 207
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 205
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 204
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 203
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 202
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 194
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 194
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 193
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 192
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 192
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 192
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 190
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 190
Delirium in acute promyelocytic leukemia patients: Two case reports 190
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 188
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 188
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 187
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 186
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 186
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 185
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 185
Isolated thrombocytopenia by splenic sequestration in hemodialyzed patients 185
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 184
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 184
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 183
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 183
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 182
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings 180
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 179
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 177
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 177
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 176
A randomized double-blind placebo-controlled study with subcutaneous recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes 176
Dendritic cells in acute promyelocytic leukaemia 175
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 173
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 171
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 170
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 169
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 168
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 168
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 168
Hepatosplenic T-cell lymphoma (HSTCL). 167
Minimal morphological criteria for defining bone marrow dysplasia: A basis for clinical implementation of WHO classification of myelodysplastic syndromes 167
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 166
Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients 165
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 165
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 164
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 164
Cellule endoteliali progenitrici e grado di attività fisica in una popolazione di pazienti nefropatici emodializzati 163
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 162
Exercise training and endothelial progenitor cells in haemodialysis patients 162
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 159
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 158
Multilineage involvement in the 5q- syndrome: A fluorescent in situ hybridization study on bone marrow smears 158
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 158
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 157
Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma 157
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 157
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 157
INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA 156
Hemophagocytic Lymphohistiocytosis in a Patient with Relapsed Chronic Lymphocytic Leukemia Treated with Ibrutinib 156
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 156
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 155
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 155
Intestinal T-cell lymphoma 154
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 154
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 154
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 153
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 153
CD34 quantitative flow cytometry study of the blastic population in acute leukemias 152
Grave colestasi di origine paraneoplastica in donna ultraottantenne con linfoma B-cellulare anaplastico misconosciuto [Severe paraneoplastic cholestasis in a octogenarian woman with unrecognized anaplastic B-cell lymphoma] 151
A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia 151
Study of prognosis in acute myeloid leukemias (AML) by cluster analysis 149
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study 149
Totale 19.353
Salva come PNG Salva come JPEG
Categoria #
all - tutte 183.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 26.542
Totale 210.147
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.395 0 0 0 0 0 328 155 374 87 518 575 358
2021/20222.856 207 338 119 141 217 146 156 164 96 243 255 774
2022/20232.771 334 144 108 304 459 371 128 273 380 25 164 81
2023/20241.610 138 155 76 50 99 244 74 98 38 50 114 474
2024/20256.513 182 174 543 283 814 579 206 302 1.005 799 834 792
2025/20269.568 1.652 908 1.525 2.474 2.643 366 0 0 0 0 0 0
Totale 37.834